Dermapharm Aktie
47,25
EUR
-0,55
EUR
-1,15
%
Dermapharm jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Dermapharm Aktie Analyse
| 27.05.26 | Dermapharm Hold | Jefferies & Company Inc. | |
| 31.03.26 | Dermapharm Hold | Jefferies & Company Inc. | |
| 10.03.26 | Dermapharm Hold | Jefferies & Company Inc. | |
| 10.03.26 | Dermapharm Hold | Jefferies & Company Inc. | |
| 27.11.25 | Dermapharm Hold | Jefferies & Company Inc. | |
| 13.11.25 | Dermapharm Hold | Jefferies & Company Inc. | |
| 08.09.25 | Dermapharm Hold | Jefferies & Company Inc. | |
| 28.08.25 | Dermapharm Hold | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 26.08.25 | Dermapharm Hold | Warburg Research | |
| 12.08.25 | Dermapharm Hold | Warburg Research | |
| 17.06.25 | Dermapharm Hold | Warburg Research | |
| 10.06.25 | Dermapharm Hold | Warburg Research | |
Werbung
Werbung